STING1 and neoplasm: Collectively, these results demonstrate that csGRP78 nanobody‐directed immunotoxin not only inhibits tumor cell proliferation but also greatly reprograms tumor microenvironment via STING activation in APCs, which may entail the adaptive antitumor immunity and expedite the efficacy of immunotherapy.